Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeted radiotherapy for neuroblastoma.

× No keyword cloud information.

38 in total

1. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.

Authors: P A Voûte; C A Hoefnagel; J de Kraker; R Valdes Olmos; D J Bakker; A J van de Kleij
Journal: Prog Clin Biol Res Date: 1991

2. The role of [131I]Metaiodobenzylguanidine in the treatment of neural crest tumors. Proceedings of an international workshop. Rome, Italy, September 6-7, 1991.

Authors:
Journal: J Nucl Biol Med Date: 1991 Oct-Dec

3. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.

Authors: L A Smets; M Janssen; M Rutgers; K Ritzen; C Buttenhuis
Journal: Int J Cancer Date: 1991-06-19 Impact factor: 7.396

4. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.

Authors: J Clerc; S Halpern; C Fourré; F Omri; C Briançon; J Jeusset; P Fragu
Journal: J Nucl Med Date: 1993-09 Impact factor: 10.057

5. gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells.

Authors: P G Montaldo; R Carbone; M Ponzoni; P Cornaglia-Ferraris
Journal: Cancer Res Date: 1992-09-15 Impact factor: 12.701

6. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.

Authors: R Mastrangelo; A Tornesello; R Riccardi; A Lasorella; S Mastrangelo; A Mancini; V Rufini; L Troncone
Journal: Eur J Cancer Date: 1995 Impact factor: 9.162

7. Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.

Authors: L S Lashford; I J Lewis; S L Fielding; M A Flower; S Meller; J T Kemshead; D Ackery
Journal: J Clin Oncol Date: 1992-12 Impact factor: 44.544

Targeted radiotherapy for neuroblastoma.

1. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.

2. The role of [131I]Metaiodobenzylguanidine in the treatment of neural crest tumors. Proceedings of an international workshop. Rome, Italy, September 6-7, 1991.

3. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.

4. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.

5. gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells.

6. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.

7. Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.

8. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").

9. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma.

10. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Review 1. Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".